GB Sciences, Inc. Stock Price - GBLX

Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Gb Sciences, Inc. (QB) GBLX OTCMarkets Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.007 -7.37% 0.088 0.099 0.085 0.099 0.095 16:29:45
Bid Price Ask Price Spread Spread % News
0.084 0.09 0.006 6.67% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
51 264,325 $ 0.088138 $ 23,297 622,210 0.0781 - 0.365
Last Trade Time Type Quantity Stock Price Currency
15:55:28 3,000 $ 0.088 USD

GB Sciences, Inc. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 22.38M 254.35M $ -22.97M - - 201.59M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
13.47k $ - 0.00% - -

more financials information »

GB Sciences, Inc. News

Loading Messages....

Latest GBLX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GBLX Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week0.080.0990.080.0910298k0.00810.00%
1 Month0.0950.1360.080.1025635k-0.007-7.37%
3 Months0.1290.1540.07810.1105618k-0.041-31.78%
6 Months0.17480.1750.07810.1253518k-0.0868-49.66%
1 Year0.3650.3650.07810.1833771k-0.277-75.89%
3 Years0.31391.560.0000030.4225986k-0.2259-71.97%
5 Years0.661.560.0000030.4211628k-0.572-86.67%

GB Sciences, Inc. Description

The Company seeks to be an innovative technology and solution company that converts the cannabis plant into medicines, therapies and treatments for a variety of ailments. The Company is developing and utilizing state of the art technologies in plant biology, cultivation and extraction techniques, combined with biotechnology, and plans to produce consistent and measurable medical-grade cannabis, cannabis concentrates and cannabinoid therapies. Although we believe that maximum shareholder value will ultimately be achieved through the development, production and marketing of certified cannabinoid medicines, therapies and treatments, in order to generate cash flow and near term profitability, we intend to cultivate and dispense cannabis for medical purposes in both Nevada and other states which permit such sales and in which we and our operating partners are able to obtain cultivation and dispensing licenses. We seek to become a trusted producer of consistent and efficacious medicinal strains and products, combining both cannabinoids and terpenes, which we intend to market in those states within the United States and in other countries where the sale of medical cannabis products are permitted. In addition, subject to obtaining Food and Drug Administrative (FDA) certification, we intend to market our cannabinoid based drug discoveries on a world-wide basis.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.